ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer

Study limitation reported by the research below: “The SBRT dose of 36.25 Gy in 5 fractions is at the lower end of doses used in practice; results may not generalize to higher SBRT dose regimens.”

Papers